Literature DB >> 23746471

The economic costs of routine INR monitoring in infants and children--examining point-of-care devices used within the home setting compared to traditional anticoagulation clinic monitoring.

James R Gaw1, Steven Crowley, Paul Monagle, Sophie Jones, Fiona Newall.   

Abstract

INTRODUCTION: The use of point-of-care (POC) devices within the home for routine INR monitoring has demonstrated reliability, safety and effectiveness in the management of infants and children requiring long-term warfarin therapy. However, a comprehensive cost-analysis of using this method of management, compared to attending anticoagulation clinics has not been reported. The aim of this study was to compare the estimated societal costs of attending anticoagulation clinics for routine INR monitoring to using a POC test in the home.
MATERIALS AND METHODS: This study used a comparative before-and-after design that included 60 infants and children managed via the Haematology department at a tertiary paediatric centre. Each participant was exposed to both modes of management at various times for a period of ≥3 months. A questionnaire, consisting of 25 questions was sent to families to complete and return. Data collected included: the frequency of monitoring, mode of travel to and from clinics, total time consumed, and primary carer's income level.
RESULTS: The home monitoring cohort saved a total of 1 hour 19 minutes per INR test compared to attending anticoagulation clinics and had a cost saving to society of $66.83 (AUD) per INR test compared to traditional care; incorporating health sector costs, travel expenses and lost time.
CONCLUSIONS: The traditional model of care requires a considerable investment of time per test from both child and carer. Home INR monitoring in infants and children provides greater societal economic benefits compared to traditional models.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ACC; AUD; Australian dollars; Children; Cost-effectiveness; HINRMP; Health economics; INR; International Normalised Ratio; International Normalised Ratio (INR); NSW; New South Wales; POC; Point-of-care (POC); RCH; Royal Children’s Hospital; Warfarin; anticoagulation clinic (outpatient); home INR monitoring program; point-of-care

Mesh:

Substances:

Year:  2013        PMID: 23746471     DOI: 10.1016/j.thromres.2013.04.028

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

Review 1.  Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism.

Authors:  Daniel M Witt; Nathan P Clark; Scott Kaatz; Terri Schnurr; Jack E Ansell
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

Review 2.  International normalized ratio self-testing and self-management: improving patient outcomes.

Authors:  Matteo Pozzi; Julia Mitchell; Anna Maria Henaine; Najib Hanna; Ola Safi; Roland Henaine
Journal:  Vasc Health Risk Manag       Date:  2016-10-12

3.  Increased Risk for Thromboembolism After Fontan Surgery: Considerations for Thromboprophylaxis.

Authors:  Suelyn Van Den Helm; Christopher Noel Sparks; Vera Ignjatovic; Paul Monagle; Chantal Attard
Journal:  Front Pediatr       Date:  2022-03-28       Impact factor: 3.418

4.  Out-of-range INR results lead to increased health-care utilization in four large anticoagulation clinics.

Authors:  Geoffrey D Barnes; Xiaokui Gu; Eva Kline-Rogers; Christopher Graves; Eric Puroll; Kevin Townsend; Ellen McMahon; Terri Craig; James B Froehlich
Journal:  Res Pract Thromb Haemost       Date:  2018-05-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.